BLFS

BioLife Solutions, Inc. $34.95 1M -0.1% 3M +31.4% YTD +46.3% as of 2026-09-11
✓Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+1.6%
Next 1 week
+1.4%
Next 1 month
-1.2%
Seasonality
Weak window historically
Next 30 days (to Oct 14): -9.6% median, 31% of the last 36 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 26
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +1.60%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.14 -0.2% · Seasonal tilt -1.0%
$31M/day volume 44% volatility +32% 1-year
52-week range · 84% of the way up · -8% from the high
$17.86$38.10

Congressional trades in BLFS Full tracker →

2 members · 3 buys / 1 sells · $18K–$95K disclosed · latest filing Jan 20, 2023.

SELL CJ Christopher L. Jacobs · traded Dec 12, 2022 $1K–$15K
BUY CJ Christopher L. Jacobs · traded Nov 8, 2022 $1K–$15K
BUY TM Tom Malinowski · traded Jun 17, 2020 $15K–$50K
BUY TM Tom Malinowski · traded Jul 7, 2020 $1K–$15K

Earnings Full history →

Next report 2026-11-05 (Thursday, after close, in 52 days) · EPS est. 0.07.

1-day std dev
10.7%
Finished up
49%
Biggest pop
+42.8%
Biggest drop
-29.5%

Standard deviation of the close-to-close move over the last 57 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.